{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:40:12Z","timestamp":1790883612206,"version":"4.1.0"},"reference-count":13,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2909,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2710.2007.00853.x","type":"journal-article","created":{"date-parts":[[2010,7,13]],"date-time":"2010-07-13T19:14:34Z","timestamp":1279048474000},"page":"483-487","source":"Crossref","is-referenced-by-count":74,"title":["Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study1"],"prefix":"10.1155","volume":"32","author":[{"given":"P. C.","family":"Heaton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Fenwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. E.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2007,9,14]]},"reference":[{"key":"10.1111\/j.1365-2710.2007.00853.x-BIB1|cit1","unstructured":"National Ambulatory Care Survey Database 2007 http:\/\/www.cdc.gov\/nchs\/about\/major\/ahcd\/ahcd1.htm"},{"key":"10.1111\/j.1365-2710.2007.00853.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jac\/33.3.387","article-title":"Hepatic side-effects of antibiotics","volume":"33","author":"Westphal","year":"1994","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1111\/j.1365-2710.2007.00853.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00002018-199615010-00007","article-title":"Antibacterial-induced hepatotoxicity. Incidence, prevention and management","volume":"15","author":"George","year":"1996","journal-title":"Drug Safety"},{"key":"10.1111\/j.1365-2710.2007.00853.x-BIB4|cit4","volume-title":"Drug Facts and Comparisons","author":"Burnham","year":"2001"},{"key":"10.1111\/j.1365-2710.2007.00853.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/17843286.1992.11718230","article-title":"Doxycycline and hepatotoxicity","volume":"47","author":"Lienart","year":"1992","journal-title":"Acta Clinica Belgica"},{"key":"10.1111\/j.1365-2710.2007.00853.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-2796.1999.00606.x","article-title":"Chronic intoxication by doxycycline use for more than 12\u2003years","volume":"246","author":"Westermann","year":"1999","journal-title":"Journal of Internal Medicine"},{"key":"10.1111\/j.1365-2710.2007.00853.x-BIB7|cit7","unstructured":"PhRMA\/FDA\/AASLD Drug-Induced Hepatotoxicity White Paper, Postmarketing Considerations, November 2000 http:\/\/www.fda.gov\/cder\/livertox\/postmarket.pdf"},{"key":"10.1111\/j.1365-2710.2007.00853.x-BIB8|cit8","volume-title":"Committee on Quality of Health Care in America. Institute of Medicine Report: To Err is Human: Building a Safer Health System","author":"Kohn","year":"1999"},{"key":"10.1111\/j.1365-2710.2007.00853.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/pds.973","article-title":"No risk of drug-associated liver injury with alpha1-adrenoreceptor blocking agents in men with BPH: results from an observational study using the GPRD","volume":"14","author":"Clifford","year":"2005","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1111\/j.1365-2710.2007.00853.x-BIB10|cit10","volume-title":"Medical Care Statistics Section CDoHSA2","author":"Managed Care Annual Statistical Report","year":"2001"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2710.2007.00853.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(97)80492-8","article-title":"Genetic predisposition to drug-induced hepatotoxicity","volume":"26","author":"Larrey","year":"1997","journal-title":"Journal of Hepatology"},{"key":"10.1111\/j.1365-2710.2007.00853.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/toxsci\/kfl078","article-title":"Hepatic gene expression profiling and lipid homeostasis in mice exposed to steatogenic drug, tetracycline","volume":"94","author":"Yin","year":"2006","journal-title":"Toxicological Sciences"},{"key":"10.1111\/j.1365-2710.2007.00853.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/oxfordjournals.epirev.a036064","article-title":"Use of automated databases for pharmacoepidemiology research","volume":"12","author":"Strom","year":"1990","journal-title":"Epidemiologic Reviews"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2007.00853.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2007.00853.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:01:12Z","timestamp":1671818472000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2007.00853.x"}},"subtitle":["Association between tetracycline or doxycycline and hepatotoxicity"],"short-title":[],"issued":{"date-parts":[[2007,9,14]]},"references-count":13,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2007.00853.x","relation":{},"ISSN":["0269-4727","1365-2710"],"issn-type":[{"value":"0269-4727","type":"print"},{"value":"1365-2710","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,14]]}}}